Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are an emerging class of glucose-lowering drugs that are increasingly used in the treatment of type 2 diabetes (T2D) and obesity
In SUMMIT, tirzepatide cut the risk of heart failure outcomes by 38% compared to placebo
SNAC temporarily increases permeability of the gastric epithelium, allowing semaglutide to cross into the bloodstream before reaching the small intestine
These mediators not only facilitate the recruitment of inflammatory cells such as macrophages and monocytes into the myocardial tissue but also trigger myocardial inflammatory responses
The blog also looks at how these peptides aid in the recovery of muscles, tendons, ligaments, and skin, focusing on their science-backed uses and their potential to improve tissue regeneration
It can also help alleviate depression symptoms such as fatigue, social withdrawal, and feelings of guilt